1,731
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Pan-immune-inflammation value is associated with poor prognosis in patients undergoing peritoneal dialysis

, , , , , , , & show all
Article: 2158103 | Received 09 Sep 2022, Accepted 05 Dec 2022, Published online: 12 Jan 2023

References

  • Li PK, Chow KM, Van de Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90–103.
  • Li PK, Ng JK, Mcintyre CW. Inflammation and peritoneal dialysis. Semin Nephrol. 2017;37(1):54–65.
  • Cohen G, Vanholder R. Special issue: immune dysfunction in uremia. Toxins (Basel). 2021;13(1):70.
  • Cai K, Luo Q, Zhu B, et al. Neutrophil-lymphocyte ratio is associated with arterial stiffness in patients with peritoneal dialysis. BMC Nephrol. 2016;17(1):191.
  • Liu S, Yang M, Zhao Q, et al. Platelet-to-Lymphocyte ratio is associated with the mortality in peritoneal dialysis patients. Iran J Kidney Dis. 2021;15(3):206–212.
  • Wen Y, Zhan X, Wang N, et al. Monocyte/lymphocyte ratio and cardiovascular disease mortality in peritoneal dialysis patients. Mediators Inflamm. 2020;2020:9852507.
  • Ran Y, Wu QN, Long YJ, et al. Association of systemic immune-inflammation index with protein-energy wasting and prognosis in patients on maintenance hemodialysis. Zhonghua Yi Xue Za Zhi. 2021;101(28):2223–2227. Chinese.
  • Fucà G, Guarini V, Antoniotti C, et al. The Pan-immune-inflammation value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the valentino and TRIBE first-line trials. Br J Cancer. 2020;123(3):403–409.
  • Pérez-Martelo M, González-García A, Vidal-Ínsua Y, et al. Clinical significance of baseline Pan-Immune-Inflammation value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy. Sci Rep. 2022;12(1):6893.
  • Fucà G, Beninato T, Bini M, et al. The Pan-immune-inflammation value in patients with metastatic melanoma receiving first-line therapy. Target Oncol. 2021;16(4):529–536.
  • Lin F, Zhang LP, Xie SY, et al. Pan-immune-inflammation value: a new prognostic index in operative breast cancer. Front Oncol. 2022; 112:830138. 3
  • Chen X, Hong X, Chen G, et al. The Pan-immune-inflammation value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor. Transl Oncol. 2022;17:101338.
  • Lee LE, Ahn SS, Pyo JY, et al. Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Clin Exp Rheumatol. 2021;129(Suppl):88–93.
  • Gambichler T, Hessam S, Cramer P, et al. Complete blood collection-based systemic inflammation biomarkers for patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2022;36(9):1593–1596.
  • Guven DC, Sahin TK, Erul E, et al. The association between the Pan-Immune-Inflammation value and cancer prognosis: a systematic review and Meta-Analysis. Cancers (Basel). 2022;14(11):2675.
  • Gambichler T, Said S, Abu Rached N, et al. Pan-immune-inflammation value independently predicts disease recurrence in patients with merkel cell carcinoma. J Cancer Res Clin Oncol. 2022;148(11):3183–3189.
  • Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton). 2006;11(1):36–41.
  • Girndt M, Trojanowicz B, Ulrich C. Monocytes in uremia. Toxins (Basel). 2020;12(5):340.
  • Vaziri ND, Pahl MV, Crum A, et al. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012;22(1):149–156.
  • Kelly CJ. T cell function in chronic renal failure and dialysis. Blood Purif. 1994;12(1):36–41.
  • Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013;9(5):255–265.
  • Dounousi E, Duni A, Naka KK, et al. The innate immune system and cardiovascular disease in ESKD: monocytes and natural killer cells. CVP. 2021;19(1):63–76.
  • Luo H, He L, Zhang G, et al. Normal reference intervals of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and systemic immune inflammation index in healthy adults: a large multi-center study from Western China. Clin Lab. 2019;65:3.
  • Meng X, Chang Q, Liu Y, et al. Determinant roles of gender and age on SII, PLR, NLR, LMR and MLR and their reference intervals defining in Henan, China: a posteriori and big-data-based. J Clin Lab Anal. 2018;32(2):e22228.
  • Li J, Li Y, Zou Y, et al. Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis. Ren Fail. 2022;44(1):1227–1235.